James Levine

CFOatCardiff Oncology· In proxies 2022–2025

Pay in FY2025+22% from the year before · Cardiff Oncology stock -35.3% the same year

James Levine was paid $1.5M in FY2025 (Dec), up 22%. Cardiff Oncology stock fell 35.3% that year.

Pay$100 in the stock at the end of FY21 → $47

Pay is from the Summary Compensation Table of each Cardiff Oncology proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

CRDF
Cardiff OncologyPublic company · 4 yr
- CFO2022 – Present · 4 yrStock in role -85%

Roles come from the proxy statements of each company.

Activity

Pay
Cardiff Oncology CFO pay rose 22% to $1.5M. The stock fell 35% in FY2025 (Dec).
DEF 14AApr 23, 2026
Pay
Cardiff Oncology CFO pay rose 38% to $1.3M. The stock rose 193% in FY2024 (Dec).
DEF 14AApr 29, 2025

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?